2013 | A novel 2-pyrone derivative, BHP, impedes oncogenic KRAS-driven malignant progression in breast cancer | CANCER LETTERS |
2018 | A selective cyclin-dependent kinase 4, 6 dual inhibitor, Ribociclib (LEE011) inhibits cell proliferation and induces apoptosis in aggressive thyroid cancer | CANCER LETTERS |
2010 | Acquired resistance to cetuximab is mediated by increased PTEN instability and leads cross-resistance to gefitinib in HCC827 NSCLC cells. | CANCER LETTERS |
2002 | Antitumoral effects of recombinant adenovirus YKL-1001, conditionally replicating in α-fetoprotine-producing human liver cancer cells | CANCER LETTERS |
2002 | Assessment of chromosomal losses and gains in hepatocellular carcinoma | CANCER LETTERS |
2010 | Aurora-A kinase inhibition enhances the cytosine arabinoside-induced cell death in leukemia cells through apoptosis and mitotic catastrophe | CANCER LETTERS |
2015 | AZD6244 inhibits cisplatin-induced ERK1/2 activation and potentiates cisplatin-associated cytotoxicity in K-ras G12D preclinical models | CANCER LETTERS |
1998 | c-erbB-2 oncoprotein assay in ovarian carcinoma and its clinical correlation with prognostic factors | CANCER LETTERS |
2021 | Cancer-initiating cells in human pancreatic cancer organoids are maintained by interactions with endothelial cells | CANCER LETTERS |
2010 | Circulating endothelial progenitor cells (EPC) for tumor vasculogenesis in gastric cancer patients | CANCER LETTERS |
2003 | Circulating numbers of endothelial progenitor cells in patients with gastric and breast cancer | CANCER LETTERS |
1997 | Comparison of biological phenotypes according to midkine expression in gastric cancer cells and their autocrine activities could be modulated by pentosan polysulfate | CANCER LETTERS |
1999 | Deletion mapping on the short arm of chromosome 8 in hepatocellular carcinoma | Cancer Lett |
1997 | Deletion of the M6P/IGF2r gene in primary hepatocellular carcinoma | CANCER LETTERS |
2015 | Deubiquitinase OTUD5 mediates the sequential activation of PDCD5 and p53 in response to genotoxic stress | CANCER LETTERS |
1999 | Differential expression of nitric oxide synthase in human stomach cancer | CANCER LETTERS |
2015 | DNAJB1 destabilizes PDCD5 to suppress p53-mediated apoptosis | CANCER LETTERS |
2016 | Downregulation of Nrf2 by the combination of TRAIL and Valproic acid induces apoptotic cell death of TRAIL-resistant papillary thyroid cancer cells via suppression of Bcl-xL | CANCER LETTERS |
2019 | Dual-targeting of EGFR and Neuropilin-1 attenuates resistance to EGFR-targeted antibody therapy in KRAS-mutant non-small cell lung cancer | CANCER LETTERS |
2020 | Elevated GCN5 expression confers tamoxifen resistance by upregulating AIB1 expression in ER-positive breast cancer | CANCER LETTERS |
2006 | Elevation of cyclin B1, active cdc2, and HuR in cervical neoplasia with human papillomavirus type 18 infection | CANCER LETTERS |
2003 | Estrogens in female thyroid cancer: Alteration of urinary profiles in pre- and post-operative cases | CANCER LETTERS |
2000 | Expression of cyclin E and p27(KIP1) in cervical carcinoma | Cancer Letters |
1998 | Expression of Fas-related genes in human hepatocellular carcinomas | CANCER LETTERS |
2009 | G-T haplotype (2677G>T/A and 3435C>T) of ABCB1 gene polymorphisms is associated with ethnic differences to paclitaxel sensitivity in cancer cells with different gene expression pattern | CANCER LETTERS |
2004 | Growth inhibitory effects of trastuzumab and chemotherapeutic drugs in gastric cancer cell lines | CANCER LETTERS |
2009 | Guggulsterone induces apoptosis in colon cancer cells and inhibits tumor growth in murine colorectal cancer xenografts | CANCER LETTERS |
2017 | HDAC6 deacetylates p53 at lysines 381/382 and differentially coordinates p53-induced apoptosis | CANCER LETTERS |
1998 | Homozygous deletions of the CDKN2 gene and loss of heterozygosity of 9p in primary hepatocellular carcinoma | CANCER LETTERS |
2013 | Human breast cancer-associated fibroblasts enhance cancer cell proliferation through increased TGF-α cleavage by ADAM17 | CANCER LETTERS |
2016 | Human telomerase reverse transcriptase (hTERT) promotes cancer invasion by modulating cathepsin D via early growth response (EGR)-1
| CANCER LETTERS |
2002 | Induction of telomerase activity during an early burst of proliferation in pancreatic regeneration | CANCER LETTERS |
2012 | Inhibition of Akt/FOXO3a signaling by constitutively active FOXO3a suppresses growth of follicular thyroid cancer cell lines | CANCER LETTERS |
2008 | Insulin-like growth factor-1 attenuates cisplatin-induced gammaH2AX formation and DNA double-strand breaks repair pathway in non-small cell lung cancer | CANCER LETTERS |
2022 | Lysophosphatidic acid-induced amphiregulin secretion by cancer-associated fibroblasts augments cancer cell invasion | CANCER LETTERS |
2019 | miR-374a-5p promotes tumor progression by targeting ARRB1 in triple negative breast cancer | Cancer Letters |
2008 | Mobilized CD34+ cells as a biomarker candidate for the efficacy of combined maximal tolerance dose and continuous infusional chemotherapy and G-CSF surge in gastric cancer | CANCER LETTERS |
2011 | Molecular portraits of intratumoral heterogeneity in human ovarian c | CANCER LETTERS |
2001 | Monthly 5-days 5-fluorouracil and low-dose leucovorin for adjuvant chemotherapy in colon cancer | CANCER LETTERS |
2006 | Perillyl alcohol inhibits the expression and function of the androgen receptor in human prostate cancer cells | CANCER LETTERS |
2013 | Restoration of ASC expression sensitizes colorectal cancer cells to genotoxic stress-induced caspase-independent cell death
| CANCER LETTERS |
2009 | Subtelomeric DNA methylation and telomere length in human cancer cells | CANCER LETTERS |
2018 | The long noncoding RNA LUCAT1 promotes tumorigenesis by controlling ubiquitination and stability of DNA methyltransferase 1 in esophageal squamous cell carcinoma | CANCER LETTERS |
2020 | The stromal loss of miR-4516 promotes the FOSL1-dependent proliferation and malignancy of triple negative breast cancer | CANCER LETTERS |
2000 | Transduction effect of antisense K-ras on malignant phenotypes in gastric cancer cells | Cancer Letters |
2007 | Trichostatin A and 5-aza-2`-deoxycytidine switch S1P from an inhibitor to a stimulator of motility through epigenetic regulation of S1P receptors | CANCER LETTERS |
2020 | Two distinct receptor-binding domains of human glycyl-tRNA synthetase 1 displayed on extracellular vesicles activate M1 polarization and phagocytic bridging of macrophages to cancer cells | CANCER LETTERS |
2008 | Variation of the 3' telomeric overhang lengths in human cells | CANCER LETTERS |